HK Stock Market Move | Goldwind Science & Technology (02208) falls more than 4% again, Blue Arrow Aerospace's Science and Technology Innovation Board IPO is suspended. The company said it is updating materials according to regulations.

Goldwind Science & Technology (02208) fell by more than 4% again, dropping by 3.91% as of press time to 13.53 Hong Kong dollars, with a turnover of 2.99 billion Hong Kong dollars. On the news front, on March 31, according to the official website of the Shanghai Stock Exchange, the initial public offering (IPO) of Blue Arrow Aerospace on the Sci-Tech Innovation Board in China, which is striving to become the first commercial aerospace stock, has been changed to a suspended status. Blue Arrow Aerospace stated that this is a procedural adjustment and they are updating materials according to regulations. It is worth noting that a number of IPO queue companies, including Blue Arrow Aerospace and Changxin Technology, have suspended their reviews, mainly due to the expiration of financial data disclosed in their listing application documents, which needs to be supplemented. UBS recently released a research report stating that it has downgraded the earnings per share forecast of Goldwind Science & Technology for 2026 to 2028 by 10% to 18%, mainly reflecting the decline in profitability of the wind farm business and the short-term gross margin pressure brought about by the conflict in the Middle East. The target price has been raised from 25 Hong Kong dollars to 26.9 Hong Kong dollars, equivalent to a forecast price-earnings ratio of 10 times for the wind turbine business in 2027 and a doubling of the wind power business price-to-book ratio. The "buy" rating is maintained.